These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 28237553)

  • 1. Alkylation of Sulfonamides with Trichloroacetimidates under Thermal Conditions.
    Wallach DR; Chisholm JD
    J Org Chem; 2016 Sep; 81(17):8035-42. PubMed ID: 27487402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation.
    Thomas AM; Serafini M; Grant EK; Coombs EAJ; Bluck JP; Schiedel M; McDonough MA; Reynolds JK; Lee B; Platt M; Sharlandjieva V; Biggin PC; Duarte F; Milne TA; Bush JT; Conway SJ
    ACS Chem Biol; 2023 Nov; 18(11):2405-2417. PubMed ID: 37874862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery.
    Biernacki K; Daśko M; Ciupak O; Kubiński K; Rachon J; Demkowicz S
    Pharmaceuticals (Basel); 2020 May; 13(6):. PubMed ID: 32485996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibition in ophthalmology: aqueous humor secretion and the development of sulfonamide inhibitors.
    Maren TH
    EXS; 2000; (90):425-35. PubMed ID: 11268528
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases.
    Krasavin M; Korsakov M; Ronzhina O; Tuccinardi T; Kalinin S; Tanç M; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):920-934. PubMed ID: 28718328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Series of Trifluoromethylisoxazolyl- and Trifluoromethylpyrazolyl- Substituted (Hetero)aromatic Sulfonamide Carbonic Anhydrase Inhibitors: Synthesis, and Convenient Prioritization Workflow for Further
    Sibinčić N; Kalinin S; Sharoyko V; Efimova J; Gasilina OA; Korsakov M; Gureev M; Krasavin M
    Med Chem; 2023; 19(2):193-210. PubMed ID: 36045518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II.
    Kılıcaslan S; Arslan M; Ruya Z; Bilen Ç; Ergün A; Gençer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1300-5. PubMed ID: 26744900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.
    Krasavin M; Korsakov M; Dorogov M; Tuccinardi T; Dedeoglu N; Supuran CT
    Eur J Med Chem; 2015 Aug; 101():334-47. PubMed ID: 26160114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds.
    Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds.
    Krasavin M; Korsakov M; Zvonaryova Z; Semyonychev E; Tuccinardi T; Kalinin S; Tanç M; Supuran CT
    Bioorg Med Chem; 2017 Mar; 25(6):1914-1925. PubMed ID: 28237553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
    Angeli A; Paoletti N; Supuran CT
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049983
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.